APA (7th ed.) Citation

M, S., L, P., F, S., JH, N., M, H., V, B., . . . DJ, L. (2026). Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy. Nature communications, 17(1), . https://doi.org/10.1038/s41467-026-71710-7

Chicago Style (17th ed.) Citation

M, Schneider, et al. "Naïve CD4+ T-cells and Disease Status at CART Infusion Correlate with Clinical Outcomes in Real-world Large B-cell Lymphoma Patients Receiving Second-line CAR T Therapy." Nature Communications 17, no. 1 (2026). https://doi.org/10.1038/s41467-026-71710-7.

MLA (9th ed.) Citation

M, Schneider, et al. "Naïve CD4+ T-cells and Disease Status at CART Infusion Correlate with Clinical Outcomes in Real-world Large B-cell Lymphoma Patients Receiving Second-line CAR T Therapy." Nature Communications, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41467-026-71710-7.